Inventor · disambiguated record
Anne-Geneviève Marcelin
Also filed as: MARCELIN ANNE-GENEVIEVE · MARCELIN ANNE-GENEVIÈVE
6 granted patents·1 pending application·1 citations·filing 2010–2021
66Inventor score
Files withASSIST PUBLIQUE - HOPITAUX DE PARIS1CALVEZ VINCENT1INSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCH MEDICALE1UNIV PARIS1UNIV PARIS DESCARTES1
Top patents by PatentIndex Score
7 records- 0168US10947323B2Capped cyclodextrin-hydrophobic moiety conjugate, cyclodextrin supramolecular polymer, and cyclodextrin-siRNA complex and method of synthesis thereofUNIV SORBONNE·Filed 2016·Granted Mar 16, 2021·1 cites·21 claims
- 0255US11617748B2Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by P. acnesUNIV PARIS DESCARTES·Filed 2020·Granted Apr 4, 2023·0 cites·12 claims
- 0352US11116763B2Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by P. acnesUNIV PARIS·Filed 2017·Granted Sep 14, 2021·0 cites·12 claims
- 0441US2023181556A1Use of psychotropic drugs for the treatment of coronavirus infectionsINSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCH MEDICALE·Filed 2021·Application pending·0 cites
- 0540US10842776B2Hycanthone derivatives and Primaquine derivatives for use in the prevention and/or the treatment of disorders associated to gammaherpesvirusASSIST PUBLIQUE—HOPITAUX DE PARIS·Filed 2017·Granted Nov 24, 2020·0 cites·24 claims
- 0634US9181294B2Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatmentUNIV PIERRE ET MARIE CURIE PARIS 6·Filed 2012·Granted Nov 10, 2015·0 cites·19 claims
- 0728US9127279B2Use of interfering rna for treating an hiv infectionCALVEZ VINCENT·Filed 2010·Granted Sep 8, 2015·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Anne-Geneviève Marcelin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →